Navigation Links
New Study Challenges How Regulators Determine Risk

A new study provides the strongest evidence yet that a key portion of the traditional dose-response model used in drug testing and risk assessment// for toxins is wrong when it comes to measuring the effects of very low doses.

Edward J. Calabrese, a scientist at the University of Massachusetts Amherst. The findings, based on a review of more than 56,000 tests in 13 strains of yeast using 2,200 drugs, are published in the journal Toxicological Sciences and offer strong backing for the theory of hormesis, Calabrese and his colleagues contend.

Calabrese says the size of the new study and the preponderance of evidence supporting hormesis, a dose-response phenomenon in which low doses have the opposite effect of high doses, is a breakthrough that should help scientists assess and predict risks from new drugs, toxicants and possibly carcinogens. Calabrese says, “This is a fundamental biological principle that has been missed.”

Calabrese says that the field of toxicology got the dose response wrong in the 1930s and this mistake has infiltrated all regulations for low-dose exposures for toxic chemicals and drugs. These low-dose effects can be beneficial or harmful, something that the regulations miss because they are currently based on high-dose testing schemes that differ greatly from the conditions of human exposures.

In this latest study, which uses data from a large and highly standardized National Cancer Institute tumor-drug screening database, Calabrese says the evidence of hormesis is overwhelming. In the study, high doses of anticancer drugs frequently inhibit yeast growth, but at low doses they enhance growth, exactly what the homesis model predicts.

Whether one accepts the hormesis theory is not the critical public policy issue, according to Calabrese. He says that the major issue is that the risk assessments models used by the federal Environmental Protection Agency and the Food and Drug Administration fail to accurately predict responses in the low-dose zone, that is, where people live most of their daily lives.

Calabrese also says challenging the existing dose-response model has profound public policy and health implications. “I believe the hormesis model is the fundamental dose-response and government testing and risk assessment procedures should reflect that,” Calabrese says. For example, in environmental regulations, it has been assumed that most carcinogens possess real or theoretical risks at low levels, and therefore must be nearly completely removed from the environments to assure public safety. Some would contend that if hormesis is the correct model for very low levels, that cleanup standards may have to be significantly changed. Others, however, see the evidence as insufficient for such radical change and worry about other factors that can influence the effects of chemicals in low doses. The new study promises to add fuel to the debate, Calabrese says.

Calabrese also suggests that the findings may have important implications for the pharmaceutical industry and medical practices. He says that hormesis is likely to identify new life-saving drugs that were missed through traditional testing and to markedly improve the accuracy of patient dosing, which will not only improve health outcomes but also reduce adverse side effects.

Source-Newswise
RM
'"/>




Related medicine news :

1. Tomato Sauce reduces Cancer Risk- Study
2. Study on obesity and heart failure
3. National Lung Study in the process
4. Study casts doubt on keyboard ills
5. Study reveals how stress can make you sick
6. Study reveals how stress can make you sick
7. Study supports vegetable diet
8. Study to look at early surgery to treat epilepsy
9. Its Never Too Late to Stop Smoking,Study Finds
10. New Technique to Study Infants Brain.
11. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/30/2016)... ... November 30, 2016 , ... The Fertility Centers of ... a Cigna Infertility Center of Excellence. The Cigna Center of Excellence recognizes participating ... honor to be designated a Cigna Infertility Center of Excellence," said Fertility Centers ...
(Date:11/30/2016)... ... 2016 , ... "I hate when the mixture of saliva and toothpaste runs ... inventor from Bridgewater, N.J. "I thought that there had to be a way to ... the patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle ...
(Date:11/30/2016)... ... November 30, 2016 , ... Center For Discovery, ... the opening of a new eating disorder treatment center location in Palm Beach ... adults and adolescents, both males and females ages 10 and older with eating ...
(Date:11/30/2016)... MA (PRWEB) , ... November 30, 2016 , ... ... for treating injured workers have been a focus of public policymakers and system ... Compensation Research Institute (WCRI) released its Medical Price Index for Workers’ Compensation, ...
(Date:11/30/2016)... ... November 30, 2016 , ... The Clinical Data Interchange Standards ... Binding Guidance goes into effect next month. Sponsors whose studies start after December ... Standards Catalog. The current FDA Data Standards Catalog specifies the use of CDISC ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen ... HIV-Selbsttests  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) ...
(Date:11/30/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The cerebrospinal fluid (CSF) acts as ... is circulated though the brain and its ventricles, the spine and the ... the brain changes significantly. As a result, intracranial ...
(Date:11/30/2016)...  Millennium Dental Technologies, Inc. announced that it has again ... of the State of California , County ... California,s Uniform Trade Secrets act, Unfair ... practices which are untrue and misleading, as well as other ... the second time in three years that Millennium found it ...
Breaking Medicine Technology: